Vincerx Pharma
(NASDAQ) VINC
Vincerx Pharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.07M
Net Income (TTM)
$22.64M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
VINC News
VINC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vincerx Pharma
Industry
Biotechnology
Sector
Health CareEmployees
13
CEO
Raquel E. Izumi, PhD
Website
vincerx.comHeadquarters
Palo Alto, CA 94306, US
VINC Financials
Key Financial Metrics (TTM)
Gross Margin
50%
Operating Margin
-19%
Net Income Margin
-20%
Return on Equity
-4%
Return on Capital
-10%
Return on Assets
-4%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$31.46M
EBITDA
$31.46M
Operating Cash Flow
$26.13M
Capital Expenditure
$0.00
Free Cash Flow
$26.13M
Cash & ST Invst.
$4.99M
Total Debt
$0.00
Vincerx Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
12
N/A
Net Income
$5.00M
+59.8%
EBITDA
$3.33M
+53.8%
Quarterly Fundamentals
Net Cash
$4.44M
+53.5%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-4.45%
N/A
Return on Invested Capital
-9.66%
N/A
Free Cash Flow
$4.45M
+42.4%
Operating Cash Flow
$4.45M
+42.4%